Pattern of Cystoid Macular Edema in Erbil

1Muhsen Ahmmed Ali Al-jubouri, 2 Ahmed Kareem Joma

1M.B.Ch.B. H.D.Ophthalmology,Kirkuk General Hospital,

2Kirkuk, Iraq, M.B.CH.B. F.I.C.M.S. (Ophth) I.C.O, Hawler Medical University, College of Medicine, Erbil, Iraq

* Corresponding,



 Cystoid Macular Edema (CME) in its various forms can be considered one of the leading causes of central vision loss in the developed world. It is not a disease itself, It represents a common pathologic sequel of the retina and occurs in a variety of pathological conditions such as, diabetic retinopathy, central or branch retinal vein occlusion, intraocular inflammation and following cataract extraction. This study was done to investigate the pattern of CME in patient attending Erbil Teaching Hospitals.

This is a hospital base prospective study that included 61 patients (75 eyes) conducted at Erbil Teaching Hospital and Rigor Teaching Hospital for six months. All patients underwent a comprehensive assessment including medical and ophthalmic history and detailed ophthalmic examination including slit lamp examination, intraocular pressure measurement (IOP), Best corrected visual acuity (BCVA), dilated fundus examination and Optical Coherence Tomography (OCT) examination.

It was found that of the 61 patients 32 (52.5%) were females and 29 (47.5%) were males. The mean age (56.4±10.8) years. Out of the 75 eyes included in the study, 41 eyes (54.66%) had diabetic retinopathy, 10 (13.34%) eyes had CME following cataract operation (Irvine-Gass syndrome), 8 eyes (10.67%) had BRVO, 6 eyes (8%) were had CRVO, 5 eyes (6.66%) had Age related Macular Degeneration, 3 eyes (4%) with uveitis, and 2 (2.67%) had Retinitis Pigmentosa. The average macular thickness was (415.6± 107).

It was concluded that diabetic retinopathy is the most common predictive factor of CME, followed by cataract surgery.  CME is more severe in diabetic retinopathy, CRVO and after cataract surgery.

Keywords: Cystoid Macular Edema, diabetic retinopathy, cataract surgery, retinal vascular diseases.